FoxHollow To Sell Extracted Plaque For Artery Disease Drug Development
This article was originally published in The Pink Sheet Daily
Executive Summary
Plaque excision system maker FoxHollow is in talks with pharma and biotech companies to aid drug development for peripheral artery disease using its SilverHawk technology, CEO Thomas says.